Evidence map›Paper›PMID 38592642›Full record

ArticleForensic toxicology2024

Determination of Δ

Ioannis Papoutsis, Vasiliki Hatzidouka, Stamatina-Panagoula Ntoupa, Apostolis Angelis, Artemisia Dona, Emmanouil Sakelliadis, Chara Spiliopoulou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Forensic toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ioannis PapoutsisDepartment of Forensic Medicine and Toxicology, Medical School, National and Kapodistrian University of Athens, Athens, Greece. ipapoutsis@med.uoa.gr.ORCID 0000-0003-2142-6935
Vasiliki HatzidoukaDepartment of Forensic Medicine and Toxicology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Stamatina-Panagoula NtoupaDepartment of Forensic Medicine and Toxicology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Apostolis AngelisDepartment of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Artemisia DonaDepartment of Forensic Medicine and Toxicology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Emmanouil SakelliadisDepartment of Forensic Medicine and Toxicology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Chara SpiliopoulouDepartment of Forensic Medicine and Toxicology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCannabidiol (CBD) products are widely used for pain relief, sleep improvement, management of seizures etc. Although the concentrations of Δ

methodsA sensitive GC/MS method for the determination of Δ

resultsFor all analytes, the LOD and LOQ were 0.06 and 0.20 ng/mL, respectively. The calibration curves were linear (R

conclusionThe results showed that Δ

Indexed as

CannabidiolDronabinolGas Chromatography-Mass SpectrometryLimit of DetectionAdultHumansMaleSolid Phase Extraction11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acidCannabidiolDronabinol11-nor-carboxy-Δ9-tetrahydrocannabinolCBD productsForensic investigationPlasmaUrineΔ9-tetrahydrocannabinol

Identifiers

PMID38592642
PMCPMC11269327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.